Canis ISSN: 2398-2942

Chondroitin sulfate

Synonym(s): Chondroitin sulphate, CS

Contributor(s): Vetstream Ltd

Introduction

Name

  • Chondroitin sulfate.

Class of drug

  • Glycosaminoglycan.
  • Nutraceutical.

Description

Storage requirements

  • Store in a dry place <25°C.
  • Keep container tightly closed.

Uses

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Indications

  • Nutritional aid in the management of degenerative joint disease.

Administration

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Precautions

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Adverse Reactions

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Further Reading

Publications

Refereed papers

  • Recent references from PubMed and VetMedResource.
  • Lenox C E, Lunn K F (2010) Effects of glucosamine-chondroitin sulfate supplementation on serum fructosamine concentration in healthy dogs. JAVMA 236 (2), 183-186 PubMed.
  • Sauv√© F, Paradis M, Refsal K R et al (2003) Effects of oral administration of meloxicam, carprofen and a nutraceutical on thyroid function in dogs with osteoarthritis. Can Vet J 44 (6), 474-479 PubMed.
  • Adebowale A, Du J, Liang Z et al (2002) The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulfate after single and multiple doses to beagle dogs. Biopharm Drug Dispos 23 (6), 217-225 PubMed.
  • Canapp S O Jr., McLaughlin R M Jr., Hoskinson J J et al (1999) Scintigraphic evaluation of glucosamine hydrochloride and chondroitin sulfate. Am J Vet Res 60 (12), 1552-1557 PubMed.
  • Boothe D M (1998) Nutraceuticals in veterinary medicine. Part II. Safety and efficacy. Comp Contin Educ Pract Vet 20 (1), 15-21 VetMedResource.
  • Boothe D M (1997) Nutraceuticals in veterinary medicine. Part I. Definitions and regulations. Comp Contin Educ Pract Vet 19 (12), 1248-1255 VetMedResource.
  • McNamara P S, Barr S C & Erb H N (1996) Hematologic, hemostatic and biochemical effects in dogs receiving an oral chondroprotective agent for thirty days. Am J Vet Res 57 (9), 1390-1394 PubMed.

Other sources of information

  • McIlwraith C W (1999) Should I recommend the use of oral glycosaminoglycans? Comp Contin Educ Pract Vet 21 (5), 450-457.

ADDED